1. Home
  2. STSS vs SCLX Comparison

STSS vs SCLX Comparison

Compare STSS & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sharps Technology Inc.

STSS

Sharps Technology Inc.

HOLD

Current Price

$1.84

Market Cap

43.8M

Sector

Health Care

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$8.50

Market Cap

48.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STSS
SCLX
Founded
2017
2011
Country
United States
United States
Employees
55
34
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
48.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
STSS
SCLX
Price
$1.84
$8.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
169.6K
92.3K
Earning Date
04-06-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$122.52
Revenue Next Year
N/A
$186.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.42
$4.20
52 Week High
$18.23
$34.27

Technical Indicators

Market Signals
Indicator
STSS
SCLX
Relative Strength Index (RSI) 48.87 58.11
Support Level $1.66 $7.73
Resistance Level $2.00 $9.51
Average True Range (ATR) 0.11 0.96
MACD -0.02 0.20
Stochastic Oscillator 25.00 68.54

Price Performance

Historical Comparison
STSS
SCLX

About STSS Sharps Technology Inc.

Sharps Technology Inc is a medical device and pharmaceutical packaging company offering patented, smart-safety syringe products to the healthcare industry. The Company's product lines focus on providing ultra-low waste capabilities that incorporate syringe technologies that use both passive and active safety features. The Company has adopted a digital asset treasury scheme focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on-chain yield generation with the Solana Ecosystem.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: